Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT

Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1534-1535. doi: 10.1007/s00259-022-06076-1. Epub 2022 Dec 12.

Authors

Kirsten Korsholm¹, Ramune Aleksyniene², Elisabeth Albrecht-Beste², Eva Soelberg Vadstrup³, Flemming Littrup Andersen^{2

4}, Barbara Malene Fischer^{2

4}

Affiliations

¹ Department of Clinical Physiology, Nuclear Medicine, and PET, Rigshospitalet, Copenhagen, Denmark. korsholmk@gmail.com.
² Department of Clinical Physiology, Nuclear Medicine, and PET, Rigshospitalet, Copenhagen, Denmark.
³ Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
⁴ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

PMID: 36508027
DOI: 10.1007/s00259-022-06076-1

No abstract available

MeSH terms

Breast Neoplasms* / diagnostic imaging
Breast Neoplasms* / pathology
Female
Fluorodeoxyglucose F18
Humans
Neoplasm Staging
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Pregnancy
Radiopharmaceuticals
Sensitivity and Specificity
Tomography, X-Ray Computed

Substances

Fluorodeoxyglucose F18
Radiopharmaceuticals